Docetaxel, Prednisone, and Vatalanib in Treating Patients With Advanced Prostate Cancer

NCT00293371 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Stopped low accrual

Conditions

Prostate Cancer

Interventions

DRUG: docetaxel
DRUG: prednisone
DRUG: vatalanib

Sponsor

University of California, San Francisco

Collaborators

[object Object]